Alzheimer Disease Vaccine - Explore the Science & Experts | ideXlab

Scan Science and Technology

Contact Leading Edge Experts & Companies

Alzheimer Disease Vaccine

The Experts below are selected from a list of 645 Experts worldwide ranked by ideXlab platform

Paula Bickford – One of the best experts on this subject based on the ideXlab platform.

  • The Promise and Perils of an Alzheimer Disease Vaccine: A Video Debate
    Journal of Neuroimmune Pharmacology, 2009
    Co-Authors: Dave Morgan, Gary Landreth, Paula Bickford

    Abstract:

    Alzheimer’s Disease (AD) is a critical health care problem that has considerable social and economic impact on society. Effective treatments have been elusive. One major causal factor for the Disease is believed to be the deposition of amyloid fibrils in the brain, which ultimately leads to neurodegeneration and cognitive dysfunction. Based on the amyloid hypothesis of Alzheimer’s Disease, many therapies presently target the amyloid beta (Aβ) peptide, the monomeric protein fragment that assembles to form fibrils. This video article takes the form of a debate between Dr. Morgan and Dr. Landreth on the merits and drawbacks of an Alzheimer’s Disease Vaccine. Click on Supplemental Material to watch the streaming video.

Dave Morgan – One of the best experts on this subject based on the ideXlab platform.

  • The Promise and Perils of an Alzheimer Disease Vaccine: A Video Debate
    Journal of Neuroimmune Pharmacology, 2009
    Co-Authors: Dave Morgan, Gary Landreth, Paula Bickford

    Abstract:

    Alzheimer’s Disease (AD) is a critical health care problem that has considerable social and economic impact on society. Effective treatments have been elusive. One major causal factor for the Disease is believed to be the deposition of amyloid fibrils in the brain, which ultimately leads to neurodegeneration and cognitive dysfunction. Based on the amyloid hypothesis of Alzheimer’s Disease, many therapies presently target the amyloid beta (Aβ) peptide, the monomeric protein fragment that assembles to form fibrils. This video article takes the form of a debate between Dr. Morgan and Dr. Landreth on the merits and drawbacks of an Alzheimer’s Disease Vaccine. Click on Supplemental Material to watch the streaming video.

Gary Landreth – One of the best experts on this subject based on the ideXlab platform.

  • The Promise and Perils of an Alzheimer Disease Vaccine: A Video Debate
    Journal of Neuroimmune Pharmacology, 2009
    Co-Authors: Dave Morgan, Gary Landreth, Paula Bickford

    Abstract:

    Alzheimer’s Disease (AD) is a critical health care problem that has considerable social and economic impact on society. Effective treatments have been elusive. One major causal factor for the Disease is believed to be the deposition of amyloid fibrils in the brain, which ultimately leads to neurodegeneration and cognitive dysfunction. Based on the amyloid hypothesis of Alzheimer’s Disease, many therapies presently target the amyloid beta (Aβ) peptide, the monomeric protein fragment that assembles to form fibrils. This video article takes the form of a debate between Dr. Morgan and Dr. Landreth on the merits and drawbacks of an Alzheimer’s Disease Vaccine. Click on Supplemental Material to watch the streaming video.